| ADR Ontology |
| ADR Term |
Delirium |
| ADR ID |
BADD_A01178 |
| ADR Hierarchy |
|
| Description |
A disorder characterized by the acute and sudden development of confusion, illusions, movement changes, inattentiveness, agitation, and hallucinations. Usually, it is a reversible condition. [CTCAE] A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2) [MeSH] |
| MedDRA Code |
10012218 |
| MeSH ID |
D003693; D003693; D003693
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
|
| Synonym |
| Acute brain syndrome | Acute delirium | Brain syndrome acute | Delirious | Delirium | Delirium due to a general medical condition | Delirium nocternal | Delirium nocturnal | Delirium toxic | Delirium, cause unknown | Disorder brain (acute) | Drug-induced delirium | Sensory deprivation delirium | Subacute delirium | Syndrome brain acute | Sundowning | Hypoactive delirium | Hyperactive delirium | Mixed delirium | Subacute Delirium | Delirium, Subacute | Deliriums, Subacute | Subacute Deliriums | Delirium of Mixed Origin | Mixed Origin Delirium | Mixed Origin Deliriums |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
